| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.472 | 2.814 | 0 | 0 | 62.870 | 326.019 | 161.000 | 308.681 | 505.092 | 1.024.048 |
| Total Income - EUR | 9.472 | 2.864 | 0 | 0 | 62.919 | 326.063 | 161.008 | 317.732 | 522.264 | 1.024.048 |
| Total Expenses - EUR | 1.160 | 981 | 630 | 688 | 58.369 | 304.821 | 160.327 | 284.761 | 490.557 | 976.661 |
| Gross Profit/Loss - EUR | 8.312 | 1.883 | -630 | -688 | 4.550 | 21.241 | 680 | 32.971 | 31.706 | 47.387 |
| Net Profit/Loss - EUR | 8.028 | 1.799 | -630 | -688 | 3.920 | 18.203 | -930 | 29.883 | 26.483 | 39.127 |
| Employees | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 1 | 2 |
Check the financial reports for the company - Vastalex Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 12 | 5 | 0 | 0 | 14.212 | 21.361 |
| Current Assets | 8.489 | 10.233 | 9.296 | 8.404 | 30.548 | 81.201 | 69.928 | 144.089 | 62.809 | 102.736 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 117 | 114 | 115 | 721 | 113 |
| Receivables | 77 | 76 | 75 | 73 | 20.764 | 77.948 | 68.527 | 141.765 | 41.187 | 71.398 |
| Cash | 8.412 | 10.157 | 9.221 | 8.331 | 9.784 | 3.137 | 1.287 | 2.209 | 20.902 | 31.225 |
| Shareholders Funds | 8.025 | 9.742 | 8.947 | 8.095 | 11.858 | 21.774 | 17.191 | 37.309 | 29.069 | 41.484 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 463 | 491 | 349 | 309 | 18.701 | 59.431 | 52.737 | 106.781 | 47.974 | 84.891 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4612 - 4612" | |||||||||
| CAEN Financial Year |
4612
|
|||||||||
Comments - Vastalex Intermed Srl